After João Neves, Paris Saint-Germain step up efforts to secure Senny Mayulu.

B2B attendees can purchase tickets in three formats: online, in-person, and VIP SAO PAULO, SAO PAULO, BRAZIL, January ...

IL, UNITED STATES, January 29, 2026 / EINPresswire.com / — Amazon Bestselling Author Melanie Verbout’s evocative, coming-of-age memoir, “Go Pick Peas: A Childhood Out of Touch,” is available worldwide ...

The new vehicle, which is based on a CLE coupe, will be the second model from Mercedes’ ultra-limited Mythos sub-brand. Mercedes’ Mythos Series targets elite collectors with ultra-luxurious, exclusive ...

The Washington Post’s publisher, Will Lewis, is leaving his role days after the company announced it was laying off one-third of its staff. The publication named finance chief Jeff D’Onofrio, who ...

Faris Tanyos is a news editor for CBSNews.com, where he writes and edits stories and tracks breaking news. He previously worked as a digital news producer at several local news stations up and down ...

The Washington Post’s publisher and CEO is stepping down amid widespread layoffs at the company, the paper announced on Saturday. In an all-company email sent on Saturday, Lewis said it’s the “right ...

Washington Post publisher and CEO Will Lewis is leaving the newspaper, the company announced on Saturday after carrying out widespread layoffs this week. "During my tenure, difficult decisions have ...

Will Lewis has stepped down as the publisher and chief executive of The Washington Post just days after layoffs struck a third of the paper’s newsroom. Advertising executive Jeff D’Onofrio, formerly ...

The Washington Post’s publisher and CEO Will Lewis has abruptly stepped down, just days after the newspaper laid off one-third of its staff, including at least 300 journalists in the newsroom. “After ...

Microsoft announced the expansion of the Microsoft Publisher Content Marketplace. This marketplace is designed to give publishers a new revenue stream, provides AI systems with scaled access to ...

Litifilimab, a humanized immunoglobulin G1 monoclonal antibody that targets blood dendritic cell antigen 2, has been granted an FDA Breakthrough Therapy Designation, according to an announcement from ...